C Difficile Infection

The double-blind, placebo-controlled, parallel-group study that aims to observe linaclotide 290 mcg in 600 adult patients with IBS-C in the US.

Researchers compared the cost-effectiveness of vancomycin, fidaxomicin, and bezlotoxumab with vancomycin as treatments for treating the first recurrence of Clostridium difficile infection.

Fecal microbiota transplant and oral metronidazole are equally effective and tolerated for C. difficile treatment.

Researchers have correlated asthma, allergic rhinitis, and atopic dermatitis to the condition.

An epidemiologist shares his knowledge about Clostridium difficile prevention and control.

Between 2012 and 2014, 19 Pomona Valley patients died from C. difficile infection. One environmental services employee quoted in the LA Times said that she had not received any training on infection control in her 12 years of employment there.

Patients with a history of congestive heart failure were at increased risk of death during study trials of the drug, which is intended to fight recurring Clostridium difficile infections.